FB Rice names Melbourne biotech partners
Australian independent IP firm FB Rice has promoted two new Melbourne partners in a bid to strengthen its biotechnology and chemistry practice.
The company has named Dr Patrick McManamny and Dr Marcus Caulfield as its newest partners. Both appointees have been working at FB Rice since 2002.
Dr McManamny is part of the firm’s biotechnology team. He advises clients on patent validity and management issues, focusing on biological drugs such as antibodies and stem cells, as well as diagnostics and drug screening technologies.
Dr Caulfield’s expertise is in organic and polymer chemistry, and he advises companies in both the animal and human health segments.
Both new partners also have clients including universities, hospitals, cooperative research centres and research institutes.
FB Rice was founded over 60 years ago and has been operating in Melbourne for the past 20 years.
Oxytocin analogue treats chronic abdominal pain
Researchers have developed a new class of oral painkillers to suppress chronic abdominal pain,...
'Low-risk' antibiotic linked to rise of dangerous superbug
A new study has challenged the long-held belief that rifaximin — commonly prescribed to...
Robotic hand helps cultivate baby corals for reef restoration
The soft robotic hand could revolutionise the delicate, labour-intensive process of cultivating...
